Single point of contact for Emerging Affiliates and Partner Business cluster Insights and Analytics. The I&A lead, supported by his/her team, provides local teams with strategic insight through quantitative advance analytics and reporting. The role will drive work streams to proactively plan, design and lead initiatives for in-line and launch products across all franchises. He /she will be also required to support the brand planning and forecasting process as needed.
Leading a team supporting Emerging Affiliates and Partner Business through actionable insights and analytics to inform the commercial strategy execution across the CSL portfolio
Oversees the business analytics deliverables across portfolio to proactively plan, manage and execute commercial data modeling and scenario analysis.
Deliver high quality, timely and actionable insights that characterize opportunities and risks and translate into clear management recommendations with associated implications for the business.
Direct work where appropriate through managed resources provided by offshore delivery center ensuring work is appropriately prioritized, meets stakeholder needs and delivered in efficient fashion
Lead continuous improvement efforts of affiliate across business analytics including but not limited to innovation in advanced analytics approaches, identification of new data where required and function capabilities
Facilitate talent development through direct coaching, continuous feedback, and ad hoc learning programs
Master’s degree in Life Sciences, Business Administration, or Engineering. MBA or PhD or other post graduate degree strongly preferred
at least 10 years of experience in the pharmaceutical industry
Team management responsibility strongly preferred
Experience in customer insights generation, omnichannel orchestration, SFE and advance data analytics.
Commercial experience strongly preferred
We encourage you to make your well-being a priority. It’s important and so are you. Learn more about how we care at CSL.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. Learn more Inclusion and Belonging | CSL.